Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
881 Irritable Bowel Syndrome (IBS)
clinical trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Hematology Oncology Consultants-Clarkston
mi
from
Clarkston, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Macomb Medical Campus
mi
from
Macomb, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Michigan Breast Specialists-Macomb Township
mi
from
Macomb, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Fairview Maple Grove Medical Center
mi
from
Maple Grove, MN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
PeaceHealth United General Medical Center
mi
from
Sedro-Woolley, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Southwest Illinois Health Services LLP
mi
from
Swansea, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph Health System-Tawas City
mi
from
Tawas City, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Advanced Breast Care Center PLLC
mi
from
Warren, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Michigan Breast Specialists-Warren
mi
from
Warren, MI
Click here to add this to my saved trials
Gastroenterology, Rheumatology Clinical Trial
Flu Vaccine Response in Patients on Biologic Therapies
Status: Enrolling, Phase II
Updated: 12/31/1969
The Clinical Research Center
mi
from
East Setauket, NY
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Central Care Cancer Center - Bolivar
mi
from
Bolivar, MO
Click here to add this to my saved trials
Gastroenterology, Hematology, Oncology Clinical Trial
A Study of Colesevelam for Lenalidomide-Associated Diarrhea
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Bergen
mi
from
Montvale, NJ
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Status: Enrolling, Phase II
Updated: 12/31/1969
Torrance Clinical Research
mi
from
Torrance, CA
Click here to add this to my saved trials
Constipation Predominant Irritable Bowel Syndrome Clinical Trial
The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling, Phase II, III
Updated: 8/14/2013
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Gastroenterology, Pulmonary / Respiratory Diseases Clinical Trial
Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial
Status: Enrolling, Phase IV
Updated: 12/31/1969
St John's Mercy Medical Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
Sleepcare Clinical Research Institute
mi
from
Stockbridge, GA
Click here to add this to my saved trials
Diarrhoea Predominant Irritable Bowel Syndrome Clinical Trial
Retrospective Study of IBS-D Patients Previously Receiving SBI
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Hamdon, CT
Click here to add this to my saved trials
Diarrhoea Predominant Irritable Bowel Syndrome Clinical Trial
Retrospective Study of IBS-D Patients Previously Receiving SBI
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Morristown, TN
Click here to add this to my saved trials
Diarrhoea Predominant Irritable Bowel Syndrome Clinical Trial
Retrospective Study of IBS-D Patients Previously Receiving SBI
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Diarrhoea Predominant Irritable Bowel Syndrome Clinical Trial
Retrospective Study of IBS-D Patients Previously Receiving SBI
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Improving the Quality of Care for Adults With Inflammatory Bowel Disease
Status: Enrolling, Phase
Updated: 12/31/1969
University of North Carolina Multidisciplinary IBD Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Improving the Quality of Care for Adults With Inflammatory Bowel Disease
Status: Enrolling, Phase
Updated: 12/31/1969
Northwestern Medicine Inflammatory Bowel Disease Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Improving the Quality of Care for Adults With Inflammatory Bowel Disease
Status: Enrolling, Phase
Updated: 12/31/1969
Inflammatory Bowel Disease Center Baylor College of Medicine Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Inflammatory Bowel Diseases Clinical Trial
Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Regenevita LLC
mi
from
Stevensville, MT
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bellevue, WA
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dothan, AL
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hollywood, FL
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Lima, OH
Click here to add this to my saved trials
Gastroenterology Clinical Trial
ALPCO Calprotectin ELISA - Measurement of Calprotectin Levels in Human Stool
Status: Enrolling
Updated: 6/27/2017
ALPCO
mi
from
Salem, NH
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
GI Care for Kids
mi
from
Atlanta, GA
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling, Phase II
Updated: 12/31/1969
Sleep Care Research Institute/Global Research Associates
mi
from
Stockbridge, GA
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling, Phase II
Updated: 12/31/1969
Multicare Health Institute for Research and Innovation
mi
from
Tacoma, WA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Efficacy and Safety of Plecanatide in Children 6 to
Status: Enrolling, Phase II
Updated: 12/31/1969
Synergy Research Site
mi
from
Crowley, LA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Fairview Lakes Medical Center
mi
from
Wyoming, MN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph Mercy Brighton
mi
from
Brighton, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph Mercy Chelsea
mi
from
Chelsea, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Newland Medical Associates-Clarkston
mi
from
Clarkston, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Walter Knox Memorial Hospital
mi
from
Emmett, ID
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Genesee Hematology Oncology PC
mi
from
Flint, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Michigan Breast Specialists-Grosse Pointe Woods
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Lehigh Valley Hospital-Hazleton
mi
from
Hazleton, PA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Oncology Hematology Associates of Saginaw Valley PC
mi
from
Saginaw, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Mary's Oncology/Hematology Associates of West Branch
mi
from
West Branch, MI
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Trial for New Treatment of Adult Patients With Irritable Bowel Syndrome
Status: Enrolling, Phase II
Updated: 12/31/1969
Cork University Hospital
mi
from
Cork,
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Status: Enrolling, Phase II
Updated: 12/31/1969
Synexus - Clinical Research Advantage - Central Phoenix Medical Clinic LLC
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Constipation Predominant Irritable Bowel Syndrome Clinical Trial
The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling, Phase II, III
Updated: 8/14/2013
Clinical Research Facility
mi
from
Boulder, CO
Click here to add this to my saved trials
Constipation Predominant Irritable Bowel Syndrome Clinical Trial
The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling, Phase II, III
Updated: 8/14/2013
Clinical Research Facility
mi
from
Greensboro, NC
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Status: Enrolling, Phase II
Updated: 7/6/2016
Wellness Clinical Research Associates
mi
from
McKinney, TX
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
Ark Clinical Research
mi
from
Long Beach, CA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Improving the Quality of Care for Adults With Inflammatory Bowel Disease
Status: Enrolling, Phase
Updated: 12/31/1969
University of Chicago Medicine Inflammatory Bowel Disease Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Improving the Quality of Care for Adults With Inflammatory Bowel Disease
Status: Enrolling, Phase
Updated: 12/31/1969
Keck Medical Center at University of Southern California Digestive Health Center (USC/Keck)
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Improving the Quality of Care for Adults With Inflammatory Bowel Disease
Status: Enrolling, Phase
Updated: 12/31/1969
St. Anthony Physicians Group Gastroenterology
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Improving the Quality of Care for Adults With Inflammatory Bowel Disease
Status: Enrolling, Phase
Updated: 12/31/1969
Midwest Gastrointestinal Associates
mi
from
Omaha, NE
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bountiful, UT
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Inflammatory Bowel Diseases Clinical Trial
Cytokines and Genes in Therapeutic Response in Crohn's Disease
Status: Enrolling, Phase
Updated: 12/31/1969
Inflammatory Bowel Disease Clinic, Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
University of California San Francisco Benioff Children's Hospita;
mi
from
San Francisco, CA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
Status: Enrolling, Phase
Updated: 12/31/1969
Gastro Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
Status: Enrolling, Phase
Updated: 12/31/1969
NYU Langone Health
mi
from
New York, NY
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel Disease
Status: Enrolling
Updated: 12/31/1969
Crohn's and Colitis Center, MGH
mi
from
Boston, MA
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling, Phase II
Updated: 12/31/1969
Cook Children's Digestive Health
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling, Phase II
Updated: 12/31/1969
Florida Research Center Inc.
mi
from
Miami, FL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling, Phase II
Updated: 12/31/1969
Unity Point Health Pediatric Gastroenterology
mi
from
Peoria, IL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Pilot Study of the Physiological Effects of an Integrative Medicine Approach in Irritable Bowel Syndrome
Status: Enrolling
Updated: 1/3/2018
Thomas Jefferson University, Marcus Institute of Integrative Health Centers
mi
from
Villanova, PA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Effects of an Amino Acid Mixture on Gastrointestinal Function, Inflammation and Fluid Balance: A Pilot Study in Patients With Inflammatory Bowel Disease
Status: Enrolling
Updated: 12/31/1969
Gastroenterology Associates
mi
from
Providence, RI
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Identifying Young Inflammatory Bowel Disease Patients at Risk for Herpes Zoster
Status: Enrolling, Phase
Updated: 12/31/1969
University of Wisconsin Digestive Health Center
mi
from
Madison, WI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Doctors Park
mi
from
East China Township, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
PeaceHealth Saint John Medical Center
mi
from
Longview, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Mary's Oncology/Hematology Associates of Marlette
mi
from
Marlette, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Marjorie Weinberg Cancer Center at Loyola-Gottlieb
mi
from
Melrose Park, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Alphonsus Medical Center-Nampa
mi
from
Nampa, ID
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
21st Century Oncology-Pontiac
mi
from
Pontiac, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Hope Cancer Center
mi
from
Pontiac, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Huron Gastroenterology PC
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Anchorage Associates in Radiation Medicine
mi
from
Anchorage, AK
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Status: Enrolling, Phase II
Updated: 12/31/1969
DHAT Research Institute
mi
from
Garland, TX
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Status: Enrolling, Phase II
Updated: 12/31/1969
Investigators Research Group
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Status: Enrolling, Phase II
Updated: 12/31/1969
Desta Digestive Disease Medical Center
mi
from
San Diego, CA
Click here to add this to my saved trials
1 2 3 4 5 6 7 8 9